ScoreComparison
Company
Score
Quality
Valuation
Financial
Technical
Why is CARsgen Therapeutics Holdings Ltd. ?
1
Weak Long Term Fundamental Strength with a 6.50% CAGR growth in Operating Profits over the last 5 years
- Company's ability to service its debt is weak with a poor EBIT to Interest (avg) ratio of -73.62
2
Flat results in Jun 26
- INVENTORY TURNOVER RATIO(HY) Lowest at 3.5 times
- INTEREST(Q) Highest at HKD 4.79 MM
3
Risky -
- The stock is trading risky as compared to its average historical valuations
- Over the past year, while the stock has generated a return of -35.31%, its profits have risen by 83.2%
4
Underperformed the market in the last 1 year
- Even though the market (Hang Seng Hong Kong) generated negative returns of -4.77% in the last 1 year, its fall in the stock was much higher with a return of -35.31%
Real-Time Research ReportHow much should you sell?
- All quantity irrespective of whether you are making profits or losses
(If sector exposure > 30%, please use optimiser tool to see which are the best stocks to hold in Pharmaceuticals & Biotechnology)
When to re-enter? - We will constantly monitor the company and review our call based on new data
Is CARsgen Therapeutics Holdings Ltd. for you?
High Risk, High Return
Absolute
Risk Adjusted
Volatility
CARsgen Therapeutics Holdings Ltd.
-33.16%
1.59
74.73%
Hang Seng Hong Kong
-5.07%
-0.26
18.70%
Quality
Management Risk
Growth
Capital StructureQuality key factors
Factor
Value
Sales Growth (5y)
167.72%
EBIT Growth (5y)
6.50%
EBIT to Interest (avg)
-49.10
Debt to EBITDA (avg)
Negative Net Debt
Net Debt to Equity (avg)
-1.30
Sales to Capital Employed (avg)
0.06
Tax Ratio
0
Dividend Payout Ratio
0
Pledged Shares
0
Institutional Holding
0
ROCE (avg)
0
ROE (avg)
0
ValuationValuation Key Factors 
Factor
Value
P/E Ratio
NA (Loss Making)
Industry P/E
Price to Book Value
9.85
EV to EBIT
-28.88
EV to EBITDA
-33.04
EV to Capital Employed
-20.18
EV to Sales
53.87
PEG Ratio
NA
Dividend Yield
NA
ROCE (Latest)
Negative Capital Employed
ROE (Latest)
-12.73%
TechnicalsTechnical key factors
Indicator
Weekly
Monthly
MACD
Bearish
Mildly Bearish
RSI
No Signal
No Signal
Bollinger Bands
Mildly Bearish
Bearish
Moving Averages
Bearish (Daily)
KST
Bearish
Mildly Bearish
Dow Theory
Mildly Bearish
Mildly Bearish
OBV
Mildly Bullish
Mildly Bearish
Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish Turned 
Financial Trend9What is working for the Company
OPERATING CASH FLOW(Y)
Highest at HKD -555.88 MM
NET PROFIT(HY)
Higher at HKD -75.99 MM
ROCE(HY)
Highest at -8.66%
RAW MATERIAL COST(Y)
Fallen by -107.93% (YoY
NET SALES(Q)
At HKD 70.59 MM has Grown at 28.95%
-5What is not working for the Company
INVENTORY TURNOVER RATIO(HY)
Lowest at 3.5 times
INTEREST(Q)
Highest at HKD 4.79 MM
Here's what is working for CARsgen Therapeutics Holdings Ltd.
Operating Cash Flow
Highest at HKD -555.88 MM and Grown
In each year in the last three yearsMOJO Watch
The company has generated higher cash revenues from business operations
Operating Cash Flows (HKD MM)
Net Profit
Higher at HKD -75.99 MM
than preceding 12 month period ended Jun 2026MOJO Watch
In the half year the company has already crossed Net Profit of the previous twelve months
Net Profit (HKD MM)
Net Sales
At HKD 70.59 MM has Grown at 28.95%
Year on Year (YoY)MOJO Watch
Near term sales trend is positive
Net Sales (HKD MM)
Raw Material Cost
Fallen by -107.93% (YoY)
MOJO Watch
The company's ability to pass on the cost of raw materials to customers has improved; this may lead to a rise in profit margin
Raw Material Cost as a percentage of Sales
Here's what is not working for CARsgen Therapeutics Holdings Ltd.
Interest
Highest at HKD 4.79 MM
in the last five periods and Increased by 14.24% (QoQ)MOJO Watch
Rising interest cost signifies increased borrowings
Interest Paid (HKD MM)
Inventory Turnover Ratio
Lowest at 3.5 times
in the last five Semi-Annual periodsMOJO Watch
Company's pace of selling inventory has slowed
Inventory Turnover Ratio
Footer loading
